Fate Therapeutics Files 2024 10-K
Ticker: FATE · Form: 10-K · Filed: Mar 5, 2025 · CIK: 1434316
| Field | Detail |
|---|---|
| Company | Fate Therapeutics Inc (FATE) |
| Form Type | 10-K |
| Filed Date | Mar 5, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, biotechnology
TL;DR
Fate Therapeutics filed its 2024 10-K. Full year financials and biz details out now.
AI Summary
Fate Therapeutics Inc. filed its 2024 10-K on March 5, 2025, reporting on its fiscal year ending December 31, 2024. The company, based in San Diego, CA, operates in the biological products sector. Key financial data and operational details for the fiscal year are presented in this comprehensive annual report.
Why It Matters
This 10-K filing provides investors and stakeholders with a detailed overview of Fate Therapeutics' financial performance, strategic initiatives, and risk factors for the fiscal year 2024, crucial for understanding the company's current standing and future prospects.
Risk Assessment
Risk Level: medium — As a biotechnology company, Fate Therapeutics faces inherent risks related to drug development, clinical trials, regulatory approvals, and market competition.
Key Numbers
- 2024 — Fiscal Year (Reporting period for the 10-K)
- 1231 — Fiscal Year End (December 31st is the end of the reporting period)
Key Players & Entities
- FATE THERAPEUTICS INC (company) — Filer
- 2024-12-31 (date) — Fiscal Year End
- 2025-03-05 (date) — Filing Date
- SAN DIEGO, CA (location) — Business Address
- 858.875.1803 (phone_number) — Business Phone
FAQ
What is Fate Therapeutics Inc.'s primary business sector?
Fate Therapeutics Inc. operates in the BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) sector, with SIC code [2836].
When was the 10-K filing submitted to the SEC?
The 10-K filing was submitted on March 5, 2025.
What is the business address of Fate Therapeutics Inc.?
The business address is 12278 SCRIPPS SUMMIT DRIVE, SAN DIEGO, CA 92131.
What is the SEC file number for Fate Therapeutics Inc.'s 10-K?
The SEC file number is 001-36076.
What is the fiscal year end date for the reported period?
The fiscal year end date for the reported period is December 31, 2024.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 5, 2025 regarding FATE THERAPEUTICS INC (FATE).